Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

<p>Differentially methylated regions with at least five CpGs, and a mean difference of greater than 20% between day 14 and baseline white blood cells</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: John A. Ligon (15024477) (author)
Diğer Yazarlar: R. Taylor Sundby (15049851) (author), Mary F. Wedekind (15049854) (author), Fernanda I. Arnaldez (15049857) (author), Jaydira Del Rivero (15049860) (author), Lori Wiener (15049863) (author), Ramaprasad Srinivasan (15049866) (author), Melissa Spencer (15049869) (author), Amanda Carbonell (15049872) (author), Haiyan Lei (14963261) (author), John Shern (15049875) (author), Seth M. Steinberg (15043179) (author), William D. Figg (15017625) (author), Cody J. Peer (14946853) (author), Sara Zimmerman (15049878) (author), Josquin Moraly (15049881) (author), Xia Xu (15049884) (author), Stephen Fox (15049887) (author), King Chan (15049890) (author), Michael I. Barbato (15049893) (author), Thorkell Andresson (15049896) (author), Naomi Taylor (15049899) (author), Karel Pacak (15049902) (author), J. Keith Killian (15049905) (author), Eva Dombi (14942359) (author), W. Marston Linehan (15049908) (author), Markku Miettinen (15049911) (author), Richard Piekarz (15035022) (author), Lee J. Helman (15049914) (author), Paul Meltzer (14956444) (author), Brigitte Widemann (15049917) (author), John Glod (15049920) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Cancer
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Endocrine-Related Cancers
Gastrointestinal Cancers
Sarcomas
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller